BeiGene Ltd., one of China's foremost developers of next-generation cancer drugs, is on the cusp of turning a profit after years of significant investments in research and development. The company has made remarkable strides towards achieving an annual operating profit, bolstered by the
A groundbreaking study conducted by Zeynep Ilgin Kolabas and her colleagues at Ludwig Maximilian University of Munich unveils the existence and function of channels between the skull and brain. This research reveals their role in trafficking immune cells and facilitating skull-specific immune
The field of cell therapy is currently witnessing groundbreaking advancements, particularly in the methods of stem cell collection and the automation of manufacturing processes. These innovations hold the potential to revolutionize the sector by significantly enhancing the efficiency, reliability,
In today's rapidly evolving scientific landscape, groundbreaking innovations are consistently transforming our understanding of the world and pushing the boundaries of what is possible. From space exploration to bioengineering, researchers are uncovering new knowledge and developing
Lupus, a chronic autoimmune disease, has long been a challenging condition to manage, often requiring treatments that come with severe side effects and necessitate lifelong administration. However, recent advancements in Chimeric Antigen Receptor (CAR) T cell therapies are providing new hope for
The ethical concerns surrounding the non-disclosure of genetic risks to participants in Alzheimer’s anti-amyloid drug trials have sparked significant debate. Eisai and Eli Lilly, the companies conducting these trials, were aware of the increased risk of brain swelling and bleeding in participants w
